Grand Forum 3











Attenzione: apre in una nuova finestra.

3 Monday, September 3, 1:15 – 2:15 pm
Defining Barrett's esophagus

Chairs:
R.E. Sampliner (Tucson) – M. Upton (Seattle)
Key note: H.D. Appelman (Ann Arbor)

  • What is the origin of the BE cell? R.F.  Souza (Tucson)
  • How does obesity contribute to activation of pro-inflammatory pathways in Barrett's esophagus?
    Are BE and Barrett carcinoma diseases of obesity and high caloric concentration? J. Reynolds (Dublin)
  • Is it cost-effective to organize mass screening program of Barrett's esophagus ? J.M. Inadomi (Seattle)
  • What is the impact on cost of care/surveillance and on decreased risk for cancer if all columnar-lined esophagus is included in Barrett esophagus? M. Westerhoff (Seattle)
  • How do different definitions of Barrett esophagus affect our interpretations of results of different 
studies related to risk for dysplasia? What kind of columnar metaplasia increases risk for adenocarcinoma? R.C. Fitzgerald (Cambridge)